Market Wrap Daily

Posted by Market Wrap Daily | Posted in: Healthcare, Recent, Stock News

Targacept Inc. (NASDAQ: TRGT) shares plunge

Targacept Inc. (NASDAQ: TRGT) shares are lower by 33% at the moment. The biotech group and partner AstraZeneca PLC (NYSE: AZN) reported disappointing Phase III clinical results for their antidepressant drug-candidate TC-5214.

Targacept, Inc. is a biopharmaceutical company. It is engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting neuronal nicotinic receptors, or NNRs.

Tags: biotech